Disc Medicine, Inc.
NASDAQDisc Medicine heads into its June 18 earnings report with short sellers quietly adding exposure and the ORTEX short score at a fresh weekly high. Short interest is the dominant story here. Bears have rebuilt their position to 15.6% of the free float — a level that places IRON firmly in the top tier of shorted biotech names. The move has been steady rather than dramatic: shorts…
Snapshot as of 11 Jun 2026
Disc Medicine heads into its June 18 earnings report with short sellers quietly adding exposure and the ORTEX short score at a fresh weekly high. Short interest is the dominant story here. Bears have rebuilt their…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IRON — free to start on ORTEX.
Sign up for free →Open IRON on ORTEX